Menlo Park, CA, United States of America

Florian Rubelt

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
5 patents (USPTO):

Title: The Innovative Mind of Florian Rubelt

Introduction: Florian Rubelt, based in Menlo Park, California, is a distinguished inventor known for his contributions to the field of immune profiling. With three patents to his name, Rubelt has made significant advancements in the methodologies and compositions related to immune receptor sequence profiling. His work focuses on enhancing our understanding of immune responses, which is crucial in various medical applications.

Latest Patents: Among his latest patents is the groundbreaking invention titled "Immune profiling by primer extension target enrichment." This invention describes methods and compositions for primer extension target enrichment of immune receptor sequences, specifically B cell receptors (BCR) and T cell receptors (TCR). The innovative approaches presented by Rubelt are pivotal for improving immune profiling techniques, facilitating better diagnostics and treatments.

Career Highlights: Florian Rubelt's career includes notable positions at leading biotechnology companies, including Roche Sequencing Solutions and Ventana Medical Systems. His experience at these organizations has allowed him to refine his expertise in sequencing technologies and immune profiling, further establishing him as a key player in the industry.

Collaborations: Throughout his career, Rubelt has fostered collaborations with talented individuals such as Jan Berka and Seoyoung Kim. Working alongside these innovative minds, he has contributed to various projects that push the boundaries of current scientific knowledge and methodologies in the field of immunology.

Conclusion: Florian Rubelt exemplifies the spirit of innovation within the realm of immunology and biotechnology. His patents and collaborative efforts reflect not only his inventiveness but also his commitment to advancing medical science. As he continues to explore new frontiers in immune profiling, Rubelt remains a name to watch in the rapidly evolving landscape of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…